Cargando…
Hyperhaemolysis in a pregnant woman with a homozygous β(0)‐thalassemia mutation and two genetic modifiers
INTRODUCTION: Patients with a homozygous β(0)‐thalassemia mutation usually have a transfusion‐dependent β‐thalassemia major phenotype. However, some β‐thalassemia patients present with a relatively mild and even normal phenotype and always have a high level of Hb F induced by genetic modifiers. METH...
Autores principales: | Jiwu, Lou, Manna, Sun, Lai, Meixiang, Ying, Zhao, Yanhui, Liu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372088/ https://www.ncbi.nlm.nih.gov/pubmed/33960744 http://dx.doi.org/10.1002/mgg3.1696 |
Ejemplares similares
-
The role of tocilizumab in the treatment of post‐transfusion hyperhaemolysis
por: Desai, Naeem, et al.
Publicado: (2023) -
Unusual survival of a twin with homozygous α0-thalassemia due to chimerism
por: Pang, Dejian, et al.
Publicado: (2020) -
Successful Management of Severe Hyperhaemolysis with Combined Tocilizumab and Rituximab in Non-Transfusion-Dependent Thalassaemia: A Case Report
por: El Afifi, Amal M., et al.
Publicado: (2022) -
Hemochromatosis in a β‐thalassemia minor patient with H63D homozygous mutation: A case report
por: Pokhrel, Nishan Babu, et al.
Publicado: (2020) -
Thrombin Generation Decrease After LMWH Administration in an Antithrombin-Deficient Pregnant Woman With a Homozygous HBS II Mutation
por: Malikova, Ivana, et al.
Publicado: (2023)